The water-retaining functional slow-release fertilizer modified by carboxymethyl chitosan.

To solve the problem of shortage of agricultural water resources and low utilization rate of fertilizer, a slow-release fertilizer based on chitosan modified water retention function was developed. Solution polymerization and semi-interpenetrating network technology were used to load urea aldehyde into carboxymethyl chitosan superabsorbent resin network. This technology realizes the simultaneous slow release of nutrients and water by using modified chitosan, which has important implications for the application of chitosan in agriculture to regulate the soil water and fertilizer conditions. The optimal preparation conditions were: MBA 0.07 %, KPS 0.8 %, AM to AA mass ratio of 0.3:1, CMC content of 10 %, AA neutralization degree 85 %, UF 20 %, AA+AM mass sum of 10 g, reaction temperature 70 °C and reaction time 2 h. The maximum water absorption rate of the optimized NC reached 172.3 g/g. The cumulative release of nitrogen in 30 days was 83.67 %. The application of NC in sandy soil promoted seed germination and growth. The comprehensive results indicate that NC has broad application prospects in arid areas based on its excellent water retention and nutrient release performance.

Efficacy and safety of anti-CD38 monoclonal antibodies in patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials.

Objectives: The current study aims to evaluate the safety and efficacy of anti-CD38 monoclonal antibodies (mAbs) among patients with relapsed/refractory multiple myeloma (RRMM) through meta-analysis. Methods: As of June 2023, we searched PubMed, Web of Science, Embase and the Cochrane Library. Randomized controlled trials (RCTs) which compared the clinical outcomes of anti-CD38 mAbs plus immunomodulatory drugs (IMiDs) or proteasome inhibitors (PIs) plus dexamethasone and IMiDs (or PIs) and dexamethasone alone for RRMM patients were included. Efficacy outcomes were mainly evaluated with progression-free survival (PFS) and overall survival (OS). The safety was analyzed with hematologic and nonhematologic treatment-emergent adverse events (TEAEs). All results were pooled using hazard ratio (HR), relative risk (RR), and their 95% confidence interval (CI) and prediction interval (PI). Results: This meta-analysis included 11 RCTs in total. Compared with IMiDs (or PIs) and dexamethasone alone, anti-CD38 mAbs in combination with IMiDs (or PIs) and dexamethasone significantly prolonged PFS (HR: 0.552, 95% CI = 0.461 to 0.659, 95% PI = 0.318 to 0.957) and OS (HR: 0.737, 95% CI = 0.657 to 0.827, 95% PI = 0.626 to 0.868) in patients with RRMM. Additionally, RRMM patients receiving anti-CD38 mAbs in combination with IMiDs (or PIs) and dexamethasone achieved higher rates of overall response (RR: 1.281, 95% CI = 1.144 to 1.434, 95% PI = 0.883 to 1.859), complete response or better (RR: 2.602, 95% CI = 1.977 to 3.424, 95% PI = 1.203 to 5.628), very good partial response (VGPR) or better (RR: 1.886, 95% CI = 1.532 to 2.322, 95% PI = 0.953 to 3.731), and minimum residual disease (MRD)-negative (RR: 4.147, 95% CI = 2.588 to 6.644, 95% PI = 1.056 to 16.283) than those receiving IMiDs (or PIs) and dexamethasone alone. For TEAEs, the rates of hematologic and nonhematologic TEAEs, including thrombocytopenia, neutropenia, upper respiratory tract infection (URTI), pneumonia, bronchitis, dyspnea, diarrhea, pyrexia, back pain, arthralgia, fatigue, insomnia, and hypertension, were higher in the anti-CD38 mAbs in combination with IMiDs (or PIs) and dexamethasone group than in the IMiDs (or PIs) and dexamethasone group. Conclusion: Our study showed that anti-CD38 mAbs in combination with IMiDs (or PIs) and dexamethasone improved PFS and OS, and achieved higher rates of overall response, complete response or better, VGPR or better, and MRD-negative, as well as higher rates of thrombocytopenia, neutropenia, URTI, pneumonia, bronchitis, dyspnea, diarrhea, pyrexia, back pain, arthralgia, fatigue, insomnia, and hypertension in RRMM patients. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42023431071.

Oncometabolite D-2-hydroxyglutarate-dependent metabolic reprogramming induces skeletal muscle atrophy during cancer cachexia.

Cancer cachexia is characterized by weight loss and skeletal muscle wasting. Based on the up-regulation of catabolism and down-regulation of anabolism, here we showed genetic mutation-mediated metabolic reprogramming in the progression of cancer cachexia by screening for metabolites and investigating their direct effect on muscle atrophy. Treatment with 93 µM D-2-hydroxyglutarate (D2HG) resulted in reduced myotube width and increased expression of E3 ubiquitin ligases. Isocitrate Dehydrogenase 1 (IDH1) mutant patients had higher D2HG than non-mutant patients. In the in vivo murine cancer cachexia model, mutant IDH1 in CT26 cancer cells accelerated cachexia progression and worsened overall survival. Transcriptomics and metabolomics revealed a distinct D2HG-induced metabolic imbalance. Treatment with the IDH1 inhibitor ivosidenib delayed the progression of cancer cachexia in murine GL261 glioma model and CT26 colorectal carcinoma models. These data demonstrate the contribution of IDH1 mutation mediated D2HG accumulation to the progression of cancer cachexia and highlight the individualized treatment of IDH1 mutation associated cancer cachexia.

Designing nanohesives for rapid, universal, and robust hydrogel adhesion.

Nanoparticles-based glues have recently been shown with substantial potential for hydrogel adhesion. Nevertheless, the transformative advance in hydrogel-based application places great challenges on the rapidity, robustness, and universality of achieving hydrogel adhesion, which are rarely accommodated by existing nanoparticles-based glues. Herein, we design a type of nanohesives based on the modulation of hydrogel mechanics and the surface chemical activation of nanoparticles. The nanohesives can form robust hydrogel adhesion in seconds, to the surface of arbitrary engineering solids and biological tissues without any surface pre-treatments. A representative application of hydrogel machine demonstrates the tough and compliant adhesion between dynamic tissues and sensors via nanohesives, guaranteeing accurate and stable blood flow monitoring in vivo. Combined with their biocompatibility and inherent antimicrobial properties, the nanohesives provide a promising strategy in the field of hydrogel based engineering.

A Fast Granular-Ball-Based Density Peaks Clustering Algorithm for Large-Scale Data.

Density peaks clustering algorithm (DP) has difficulty in clustering large-scale data, because it requires the distance matrix to compute the density and δ -distance for each object, which has O(n2) time complexity. Granular ball (GB) is a coarse-grained representation of data. It is based on the fact that an object and its local neighbors have similar distribution and they have high possibility of belonging to the same class. It has been introduced into supervised learning by Xia et al. to improve the efficiency of supervised learning, such as support vector machine, k -nearest neighbor classification, rough set, etc. Inspired by the idea of GB, we introduce it into unsupervised learning for the first time and propose a GB-based DP algorithm, called GB-DP. First, it generates GBs from the original data with an unsupervised partitioning method. Then, it defines the density of GBs, instead of the density of objects, according to the centers, radius, and distances between its members and centers, without setting any parameters. After that, it computes the distance between the centers of GBs as the distance between GBs and defines the δ -distance of GBs. Finally, it uses GBs' density and δ -distance to plot the decision graph, employs DP algorithm to cluster them, and expands the clustering result to the original data. Since there is no need to calculate the distance between any two objects and the number of GBs is far less than the scale of a data, it greatly reduces the running time of DP algorithm. By comparing with k -means, ball k -means, DP, DPC-KNN-PCA, FastDPeak, and DLORE-DP, GB-DP can get similar or even better clustering results in much less running time without setting any parameters. The source code is available at https://github.com/DongdongCheng/GB-DP.

A Retrospective Study of the Functional Outcomes in Patients with Proximal Humeral Bone Defect after Shoulder Fusion or Prosthetic Replacement.

AIMS: The reconstruction of proximal humeral defects resulting from tumor resection is challenging. The purpose of this work was to retrospectively study the functional outcomes in patients with large bone defects after the resection of proximal humeral tumors. METHODS: We performed a retrospective analysis of 49 patients with malignant or aggressive benign tumors in the proximal humerus at our institution between 2010 and 2021. Forty-nine patients were included in the study (prosthetic replacement, n = 27; shoulder arthrodesis, n = 22). The mean follow-up was 52.8 months (range, 14-129 months). The factors evaluated included the Musculoskeletal Tumor Society (MSTS) functional score, Constant Murley Score (CMS), and complications. RESULTS: Of the 49 patients enrolled in the study, 35 were disease-free by the time of the latest follow-up, and 14 died because of the disease. Adjuvant therapies and medical comorbidities were similar between the two groups. Osteosarcoma was the most common abnormality among all the patients. The mean MSTS scores for surviving patients in the prosthesis and arthrodesis groups were 57.4% and 80.9%, respectively. The mean CMS score for the surviving patients in the prosthesis group was 43.47, and it was 61.44 for arthrodesis cases. Patients with shoulder arthrodesis demonstrated evidence of bony union at a mean of 4.5 months. CONCLUSIONS: Shoulder arthrodesis is a reliable reconstructive procedure in patients with large bone defects after the resection of proximal humeral tumors for pediatric osteosarcoma patients. Moreover, prosthetic replacement with anatomical implants results in poor function in older metastasis patients with large bone defects and resection of the deltoid muscle.

Network interpenetrating slow-release nitrogen fertilizer based on carrageenan and urea: A new low-cost water and fertilizer regulation carrier.

Modern agriculture presents new requirements of low cost, high water retention and degradability for superabsorbent and slow-release fertilizers. In this study, carrageenan (CG), acrylic acid (AA), N, N '-methylene diacrylamide (MBA), urea and ammonium persulfate (APS) were used as raw materials. A kind of high water absorption, water retention, nitrogen slow release and biodegradable carrageenan superabsorbent (CG-SA) was prepared by grafting copolymerization. The optimal CG-SA was obtained with a water absorption rate of 680.45 g/g by orthogonal L18(3)7 experiments and single-factor experiments. The water absorption behavior of CG-SA in deionized water and salt solution were studied. The CG-SA was characterized before and after degradation by FTIR, SEM. The nitrogen release behavior and kinetic characteristics of CG-SA were investigated. In addition, CG-SA degraded 58.33 % and 64.35 % in soil at 25 °C and 35 °C after 28 days. All the results indicated that the low-cost and degradable CG-SA can achieve simultaneous slow release of water and nutrients, which is expected to be widely used as a new water-fertilizer integration technology in arid and poor areas.

[Application of absorbable anchor combined with Kirschner wire in reconstruction of extension function of old mallet finger].

Objective: To investigate the feasibility and effectiveness of absorbable anchor combined with Kirschner wire fixation in the reconstruction of extension function of old mallet finger. Methods: Between January 2020 and January 2022, 23 cases of old mallet fingers were treated. There were 17 males and 6 females with an average age of 42 years (range, 18-70 years). The cause of injury included sports impact injury in 12 cases, sprain in 9 cases, and previous cut injury in 2 cases. The affected finger included index finger in 4 cases, middle finger in 5 cases, ring finger in 9 cases, and little finger in 5 cases. There were 18 patients of tendinous mallet fingers (Doyle type Ⅰ), 5 patients were only small bone fragments avulsion (Wehbe type ⅠA). The time from injury to operation was 45-120 days, with an average of 67 days. The patients were treated with Kirschner wire to fix the distal interphalangeal joint in a mild back extension position after joint release. The insertion of extensor tendon was reconstructed and fixed with absorbable anchors. After 6 weeks, the Kirschner wire was removed, and the patients started joint flexion and extension training. Results: The postoperative follow-up ranged from 4 to 24 months (mean, 9 months). The wounds healed by first intention without complications such as skin necrosis, wound infection, and nail deformity. The distal interphalangeal joint was not stiff, the joint space was good, and there was no complication such as pain and osteoarthritis. At last follow-up, according to Crawford function evaluation standard, 12 cases were excellent, 9 cases were good, 2 cases were fair, and the good and excellent rate was 91.3%. Conclusion: Absorbable anchor combined with Kirschner wire fixation can be used to reconstruct the extension function of old mallet finger, which has the advantages of simple operation and less complications.

K-Means Clustering With Natural Density Peaks for Discovering Arbitrary-Shaped Clusters.

Due to simplicity, K-means has become a widely used clustering method. However, its clustering result is seriously affected by the initial centers and the allocation strategy makes it hard to identify manifold clusters. Many improved K-means are proposed to accelerate it and improve the quality of initialize cluster centers, but few researchers pay attention to the shortcoming of K-means in discovering arbitrary-shaped clusters. Using graph distance (GD) to measure the dissimilarity between objects is a good way to solve this problem, but computing the GD is time-consuming. Inspired by the idea that granular ball uses a ball to represent the local data, we select representatives from a local neighborhood, called natural density peaks (NDPs). On the basis of NDPs, we propose a novel K-means algorithm for identifying arbitrary-shaped clusters, called NDP-Kmeans. It defines neighbor-based distance between NDPs and takes advantage of the neighbor-based distance to compute the GD between NDPs. Afterward, an improved K-means with high-quality initial centers and GD is used to cluster NDPs. Finally, each remaining object is assigned according to its representative. The experimental results show that our algorithms can not only recognize spherical clusters but also manifold clusters. Therefore, NDP-Kmeans has more advantages in detecting arbitrary-shaped clusters than other excellent algorithms.

Ebastine exerts antitumor activity and induces autophagy by activating AMPK/ULK1 signaling in an IPMK-dependent manner in osteosarcoma.

Numerous studies have confirmed that in addition to interfering with the tumor inflammatory environment, anti-inflammatory agents can directly increase apoptosis and sensitivity to conventional therapies and decrease invasion and metastasis, making them useful candidates for cancer therapy. Here, we first used high-throughput screening and had screened one compound candidate, ebastine (a H1-histamine receptor antagonist), for osteosarcoma therapy. Cell viability assays, colony formation assays, wound healing assays, and Transwell assays demonstrated that ebastine elicited antitumor effects in osteosarcoma cells. In addition, ebastine treatment exerted obvious effects on cell cycle arrest, metastasis inhibition, apoptosis and autophagy induction both in vitro and in vivo. Mechanistically, we observed that ebastine treatment triggered proapoptotic autophagy by activating AMPK/ULK1 signaling in osteosarcoma cells. Treatment with the AMPK inhibitor dorsomorphin reversed ebastine-induced apoptosis and autophagy. More importantly, we found that IPMK interacted with AMPK and functioned as a positive regulator of AMPK protein in osteosarcoma cells. A rescue study showed that the induction of autophagy and activation of the AMPK/ULK1 signaling pathway by ebastine treatment were reversed by IPMK knockdown, indicating that the activity of ebastine was IPMK dependent. We provide experimental evidence demonstrating that ebastine has antitumor activity in osteosarcoma and promotes autophagy by activating the AMPK/ULK1 signaling pathway, which is IPMK dependent. Our results provide insight into the clinical application potential of ebastine, which may represent a new potential therapeutic candidate for the treatment of osteosarcoma.

Bio-based Polyurethane Based on a Dynamic Covalent Network with Damage Tolerance for Controlled Release of Fertilizers.

Bio-based polyurethanes are promising for the controlled release of nutrients and fertilizers, but their toughness and plasticity need to be improved. We developed a smooth, dense, elastic, and indestructible bio-based polyurethane (BPU) coating with a nutrient controlled release ∼150% superior, a tensile strength ∼300% higher, and a toughness ∼1200% higher than those for the original BPU coating. Through a one-step reaction of soybean oil polyols (accounting for more than 60%), isocyanate, and benzil dioxime, the dynamic covalent network based on oxime-carbamate replaces part of irreversible covalent cross-linking. The dynamic fracture-bonding reaction in the modified coating BPU can effectively promote the hydrogen bond recombination and oxime-carbamate chain migration in the coating process, which avoids the structural defects caused by coating tear and fertilizer collision. This work provides a simple and versatile strategy for building controlled-release fertilizer coatings.

Long-Term Follow-Up of Biological Reconstruction with Free Fibular Graft after Resection of Extremity Diaphyseal Bone Tumors.

This study aimed to evaluate the clinical outcomes and complications of reconstruction with a composite free fibula inside other biological grafts. We retrospectively reviewed 26 patients who underwent reconstruction after bone tumor resection of the diaphysis of the long bone. Surgical data, time to bony union, functional outcomes, and complications were evaluated in all cases. The median follow-up was 72.5 months. The limb salvage rate was 100%. Primary osseous union was achieved in 90.4% of the junctions. The union rates at the metaphyseal and diaphyseal junctions were 100% and 85.7%, respectively (p = 0.255). The mean time of bony union in the upper (87.5%) and lower (91.7%) extremity was 4.6 ± 1.6 months and 6.9 ± 2 months, respectively. The mean MSTS score was 27.2 ± 3.2, with a mean MSTS rating of 90.7%. Complications occurred in 15.4% of the cases. The administration of vascularized or non-vascularized grafts did not significantly influence the union time (p = 0.875), functional outcome (p = 0.501), or blood loss (p = 0.189), but showed differences in operation time (p = 0.012) in lower extremity reconstruction. A composite free fibula inside other biological grafts provides a reasonable and durable option for osseous oncologic reconstruction of the long bone diaphysis of the extremities with an acceptable rate of complications. A higher union rate was achieved after secondary bone grafting. In lower-extremity reconstruction, two plates may be considered a better option for internal fixation. Vascularizing the fibula did not significantly affect the union time.

Environmentally friendly hydrogel: A review of classification, preparation and application in agriculture.

Superabsorbent hydrogel (SH) is three-dimensional (3D) cross-linked hydrophilic polymer that can absorb and retain large quantities of water or other aqueous solutions. SH is made of water-affinity monomers and is widely used in biomedicine, wastewater treatment, hygiene and slow-release fertilizers (SRFs). This article focused on the preparation methods of SH, superabsorbent hydrogel composite and the application of SH in agriculture. By selecting various synthetic technologies and cross-linking agents, a series of chemical cross-linking or physical networks can be designed and tailored to meet specific applications. In view of the excellent characteristics of water absorption, biodegradability, water retention and slow-release capacity, SH occupies a dominant position in the SRFs market. In this work, the agricultural application of SH in double coated SRFs and nutrients carriers is also discussed. Some mechanisms related to the nutrient release were analyzed by mathematical models. In addition, some agronomic benefits of using superabsorbent hydrogels in improving water absorption, water holding capacity and increasing crop yields were also discussed. Although SH has certain shortcomings, from the perspective of long-term development, it will further show great potential in sustainable agriculture.

[Effects of large-grained activated humic acid fertilizer on soil aggregates and organic carbon in apple orchard soil]. / å¤§é¢—ç²’æ´»åŒ–è æ¤é ¸è‚¥å¯¹è‹¹æžœåœŸå£¤å›¢èšä½“å’Œæœ‰æœºç¢³çš„å½±å“.

The new large-grained activated humic acid fertilizer (LAF) can significantly reduce the amount of chemical fertilizer application and stable fruit yield. Understanding its impacts on soil aggregates and organic carbon is an important basis for revealing its role in driving soil structure of apple orchard. There were four LAF treatments: LAF1 (full fertilization, fertilization period and mass ratio (the same below), germination stage: fruit expansion stage: maturity stage=3:4:3), LAF2 (full fertilization, germination stage: fruit expansion stage: maturity stage=2:3:5), LAF3 (fertilizer application reduction by 1/4, germination stage: fruit expansion stage: maturity stage=2:3:5), LAF4 (fertilizer application reduction by 1/3, germination stage: fruit expansion stage: maturity stage=2:3:5); with no fertilization as control (CK). In a four-year pot experiment, we examined the composition, stabi-lity and organic carbon content of soil aggregates under different fertilization treatments. The results showed that: 1) compared with CK, each treatment of LAF increased the content of >2 mm and 2-0.25 mm aggregate by 53.4%-77.5% and 12.3%-17.0%, respectively. The application of LAF significantly increased the content of soil water stable aggregates, and such effects were positively related with application amount. The content of soil water stable aggregate was the highest in the LAF1 treatment. 2) There was no significant difference in aggregate content of each particle size among LAF treatments, with the proportion of aggregate content of 2-0.25 mm particle size being the highest. 3) Compared with CK, all LAF treatments significantly increased the average weight diameter (MWD) and geometric mean diameter (GMD), and reduced the fractal dimension (D). LAF1 treatment had the highest MWD and GMD values, and had the strongest effect on the stability of soil aggregates. 4) Except for LAF4 treatment, the content of soil organic carbon in other LAF treatments was significantly higher than that in CK, and the content of soil organic carbon in LAF2 treatment was the highest. All LAF treatments increased the organic carbon content of soil aggregates with each particle size. LAF1, LAF2, and LAF3 treatments significantly increased the organic carbon of aggregates with particle size >2 mm. Particle size >2 mm had the highest contribution to the total organic carbon. The contribution rate of water stable large aggregate organic carbon to total organic carbon of LAF treatment was significantly higher than that of CK, which was all higher than 66.0%, and that of LAF1 treatment was the highest. In conclusion, the application of LAF enhanced the formation and stability of water stable aggregates and increased organic carbon content of aggregates in apple orchard soil, with the best performance of the full application. The application of LAF could be used as an effective measure to improve soil structure and fertility in apple orchard.

Identification of Common Oncogenic Genes and Pathways Both in Osteosarcoma and Ewing's Sarcoma Using Bioinformatics Analysis.

This study was aimed at exploring common oncogenic genes and pathways both in osteosarcoma and Ewing's sarcoma. Microarray data were obtained from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were identified using the limma package. Then, protein-protein interaction (PPI) networks were constructed and hub genes were identified. Furthermore, functional enrichment analysis was analyzed. The expression of common oncogenic genes was validated in 38 osteosarcoma and 17 Ewing's sarcoma tissues by RT-qPCR and western blot compared to normal tissues. 201 genes were differentially expressed. There were 121 nodes and 232 edges of the PPI network. Among 12 hub genes, hub genes FN1, COL1A1, and COL1A2 may involve in the development of osteosarcoma and Ewing's sarcoma. And they were reduced to expression both in osteosarcoma and Ewing's sarcoma tissues at mRNA and protein levels compared to normal tissues. Knockdown of FN1, COL1A1, and COL1A2 enhanced the cell proliferation and migration of U2OS under the restriction of cisplatin. Our findings revealed the common oncogenic genes such as FN1, COL1A1, and COL1A2, which may act as antioncogene by enhancing cisplatin sensitivity in osteosarcoma cells, and pathways were both in osteosarcoma and Ewing's sarcoma.

Sulfated alginate oligosaccharide exerts antitumor activity and autophagy induction by inactivating MEK1/ERK/mTOR signaling in a KSR1-dependent manner in osteosarcoma.

Alginate oligosaccharide (AOS) has the function to inhibit tumor progression and the sulfated modification can enhance the antitumor activity. To date, the function and mechanism of sulfated AOS (AOS-SO4) in tumors remain largely elusive. We prepared AOS by the enzymatic degradation of alginate, collected AOS-SO4 by sulfating following the canonical procedure. Using these materials, in vitro assays showed that both AOS and AOS-SO4 elicited antitumor effects in osteosarcoma cells. Sulfated modification significantly enhanced the antitumor activity. In addition, AOS-SO4 had obvious effects on cell cycle arrest, apoptosis, and autophagy induction in vitro and in vivo. Mechanistically, we observed that AOS-SO4 treatment triggered proapoptotic autophagy by inhibiting MEK1/ERK/mTOR signaling. The ERK activator reversed AOS-SO4-induced autophagy. More importantly, we found that KSR1 interacted with MEK1 and functioned as a positive regulator of MEK1 protein in osteosarcoma cells. High KSR1 expression was significantly associated with poor survival in osteosarcoma patients. Together, these results suggest that AOS-SO4 has a better antitumor effect in osteosarcoma by inhibiting MEK1/ERK/mTOR signaling, which is KSR1-dependent; thus, AOS-SO4 can be a new potential therapeutic candidate for the treatment of osteosarcoma.

A novel synthetic slow release fertilizer with low energy production for efficient nutrient management.

Chemical synthetic slow release fertilizer had become a major breakthrough in the green fertilizer industry due to its superior nutrient management and degradation properties. However, the traditional chemical synthetic slow release fertilizers contain only nitrogen and consume high energy during drying. Herein, a low cost green chemical synthetic slow release fertilizer (PSRF/KCl) was prepared from urea, formaldehyde and diammonium phosphate by spray drying method. Compared with the traditional drying process, the comprehensive energy consumption is reduced by 38.13%. The SEM, FTIR, and TG characteristics of PSRF/KCl showed that it has excellent water solubility, special morphological characteristics and thermal properties. In addition, the application of PSRF/KCl in Chinese cabbage showed that PSRF/KCl could increase the yield by 26.2%. All the results showed that PSRF/KCl is a green chemical synthetic slow release fertilizer, which has broad application prospects in modern sustainable agriculture, and its matching spray drying process can effectively reduce production costs.

Serglycin induces osteoclastogenesis and promotes tumor growth in giant cell tumor of bone.

Giant cell tumor of bone (GCTB) is an aggressive osteolytic bone tumor characterized by the within-tumor presence of osteoclast-like multinucleated giant cells (MGCs), which are induced by the neoplastic stromal cells and lead to extensive bone destruction. However, the underlying mechanism of the pathological process of osteoclastogenesis in GCTB is poorly understood. Here we show that the proteoglycan Serglycin (SRGN) secreted by neoplastic stromal cells plays a crucial role in the formation of MGCs and tumorigenesis in GCTB. Upregulated SRGN expression and secretion are observed in GCTB tumor cells and patients. Stromal-derived SRGN promotes osteoclast differentiation from monocytes. SRGN knockdown in stromal cells inhibits tumor growth and bone destruction in a patient-derived orthotopic xenograft model of mice. Mechanistically SRGN interacts with CD44 on the cell surface of monocytes and thus activates focal adhesion kinase (FAK), leading to osteoclast differentiation. Importantly, blocking CD44 with a neutralizing antibody reduces the number of MGCs and suppresses tumorigenesis in vivo. Overall, our data reveal a mechanism of MGC induction in GCTB and support CD44-targeting approaches for GCTB treatment.

Clinical significance of FBXW7 tumor suppressor gene mutations and expression in human colorectal cancer: a systemic review and meta-analysis.

BACKGROUND: Various studies investigating the clinical significance of FBXW7 mutation and/or expression have yielded inconclusive results in colorectal cancer (CRC) patients. Therefore, the present meta-analysis summarizes previous evidence and evaluates the clinical significance, including the prognostic role, of FBXW7 status in CRCs. METHODS: The meta-analysis was conducted by searching the databases of PubMed, China National Knowledge Infrastructure (CNKI), WANFANG data, Web of Science, Embase, and Web of Science. Pooled odds ratios (ORs) and hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) were calculated to assess the relationships between FBXW7 status and clinicopathological features and survival in CRC, respectively. RESULTS: Ten studies involving 4199 patients met the inclusion criteria and included in our meta-analysis. FBXW7 mutation/low expression was obviously correlated with advanced T stage (OR = 0.44, 95% CI: 0.27-0.74, P <  0.01) and lymph node metastasis (OR = 1.88, 95% CI: 1.40-2.53, P <  0.01), but was not associated with other parameters. Further investigation found that FBXW7 mutation/low expression predicted poor OS (HR = 1.25, 95% CI: 1.06-1.47, P <  0.01), but not DFS in CRC (HR = 1.04, 95% CI: 0.60-1.82, P = 0.88). Subgroup analysis found that FBXW7 status was obviously correlated with OS in cohorts recruited after 2009 (HR = 1.32, 95% CI: 1.17-1.50, P <  0.01), from eastern Asia (HR = 1.27, 95% CI: 1.04-1.55, P = 0.02), detected by immunohistochemistry/qRT-PCR (HR = 1.39, 95% CI: 1.22-1.59, P <  0.01), and analysed with multivariate method (HR = 1.47, 95% CI: 1.25-1.74, P <  0.01). CONCLUSIONS: This study indicates that FBXW7 status, expression level especially, is associated with OS but not DFS in CRC. FBXW7 expression level may function as a prognostic biomarker in CRC.

Chitooligosaccharides inhibit tumor progression and induce autophagy through the activation of the p53/mTOR pathway in osteosarcoma.

Osteosarcoma is the most common primary sarcoma of bone. The use of Chitooligosaccharide (COS) as a drug carrier is an emerging new strategy for cancer therapy. However, the application of COS in osteosarcoma has not been reported. Here, we investigated the influence of COS on osteosarcoma, and suggested the underlying mechanism. Initially, we obtained COS with a low-degree-polymerized (DP = 2-6) by enzymatic hydrolysis. Using these COS materials, in vitro assays showed that COS elicited the anti-tumor activity against osteosarcoma cells. We found that COS had significant effects on cell growth, metastasis inhibition, apoptosis and autophagy induction, and triggered pro-apoptosis autophagy through p53/mTOR signaling pathway in osteosarcoma cells. In addition, the COS also inhibited tumor growth and metastasis in an osteosarcoma xenograft model in vivo. Finally, we showed that COS could increase sensitivity to chemotherapy of cisplatin in vitro. Thus, we provide experimental evidence to demonstrate that COS has anti-tumor effect on osteosarcoma, and COS can be a new potential therapeutic candidate for the treatment of osteosarcoma.